NEW YORK – The Multiple Myeloma Research Foundation (MMRF) and the Dana Farber Cancer Institute announced on Thursday that they have partnered to study smoldering multiple myeloma (SMM), a precancerous condition that progresses to active multiple myeloma in around 10 percent of patients every year.